News

Global energy consumption in 2050 could be reduced to the levels of the 1960s and still provide a decent standard of living for a population three times larger, according to a new study.

A combination of two substances secreted by the immune system can cure and prevent rotavirus infection, as well as potentially treat other viral infections that target epithelial cells.

Caltech researchers have developed a new type of multiplexed test with a low-cost sensor that may enable the at-home diagnosis of a COVID infection through rapid analysis of small volumes of saliva or blood, without the involvement of a medical professional, in less than 10 minutes.

Speech and singing spread saliva droplets, a phenomenon that has attracted much attention in the current context of the COVID-19 pandemic. Scientists sought to shed light on what takes place during conversations.

Agricultural scientists and engineers at the University of Adelaide have identified a potential new tool for screening cereal crops for frost damage. The research has shown barely plants can be screened successfully for frost damage with image technology, without additional destruction.

Researchers at Harvard Medical School and the Institute of Science and Technology Austria have discovered a key control mechanism that cells use to self-organize in early embryonic development.

Microscopic fibers created during the laundry cycle can cause damage to the gills, liver and DNA of marine species, according to new research.

The Academic Medical Center (AZP) in Paramaribo, Suriname, successfully studied an efficient method to collect COVID-19 antibody-containing plasma from recovered Covid-19 patients to treat critically ill patients. The plasma donation and plasma preparation is supported by the innovative Dutch blood filter HemoClear.

Cobra Biologics (Cobra) and Scancell Holdings plc (Scancell), announced that they have entered into a collaboration for Cobra to manufacture Scancell’s COVID-19 vaccine. Scancell’s DNA vaccine will target the SARS-CoV-2 nucleocapsid (N) protein plus the key receptor binding domain of the spike (S) protein to generate both T cell responses and virus neutralising antibodies against the SARS-CoV-2 virus.

Samplix launched a new service into today’s cutting-edge gene-editing technology, CRISPR. Xdrop™ is Samplix’ proprietary technology to enrich genomic regions longer than 100 kb from as little as 1 ng genomic DNA and with single-molecule resolution. Unlike other target enrichment methods, Xdrop™ requires knowledge of only a short sequence within or flanking the target region for efficient target selection.